Pamufetinib (TAS-115) for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A double-blind, multicenter, phase 2b Clinical Trial

Journal:
American Journal of Respiratory and Critical Care Medicine
Published:
DOI:
10.1093/ajrccm/aamag125
Affiliations:
16
Authors:
15
Go to article
Institutions Authors Share
Kanagawa Cardiovascular and Respiratory Center, Japan
2.000000
 0.13
Tokushima University, Japan
2.000000
 0.13
Kyushu University, Japan
1.000000
 0.07
National Hospital Organization Kyushu Medical Center, Japan
1.000000
 0.07
Kindai University, Japan
1.000000
 0.07
Yamaguchi University, Japan
1.000000
 0.07
Hiroshima Prefectural Hospital, Japan
1.000000
 0.07
Sapporo Medical University, Japan
1.000000
 0.07
Institute of Science Tokyo Hospital, Japan
1.000000
 0.07
Omori Medical Center, Toho University, Japan
1.000000
 0.07
Tosei General Hospital, Japan
0.500000
 0.03
Aichi Medical University, Japan
0.500000
 0.03
Kinki-chuo Chest Medical Center, Japan
0.500000
 0.03
Osaka Fukujuji Hospital, Osaka Anti-Tuberculosis Association, Japan
0.500000
 0.03
Tokorozawa Mihara General Hospital, Japan
0.500000
 0.03
Nippon Medical School, Japan
0.500000
 0.03
Interested in Cardiovascular Medicine and Haematology?